Citadel Advisors’s Kitov Pharma Ltd. Warrants KTOVW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-14,592
Closed -$1K 11853
2020
Q3
$1K Sell
14,592
-7,226
-33% -$693 ﹤0.01% 9984
2020
Q2
$4K Buy
+21,818
New +$1.25K ﹤0.01% 9677

Citadel Advisors's KTOVW Position: Q4 2020 in Review

Citadel Advisors sold out of Kitov Pharma Ltd. Warrants (KTOVW) in Q4 2020, closing a stake of 14,592 shares — an estimated $1K sold.

Citadel Advisors first reported a position in KTOVW in Q2 2020 and held it in 2 quarters. The position peaked at $4K in Q2 2020. 0 funds tracked by Wall St. Rank hold KTOVW as of Q4 2020.

  • Citadel Advisors reported no remaining Kitov Pharma Ltd. Warrants position as of Q4 2020 after selling out during the quarter.
  • Citadel Advisors sold 14,592 Kitov Pharma Ltd. Warrants shares in Q4 2020, an estimated $1K.
  • Citadel Advisors first reported a position in Kitov Pharma Ltd. Warrants in Q2 2020 and held it in 2 quarters.
  • Citadel Advisors's Kitov Pharma Ltd. Warrants position peaked at $4K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Kitov Pharma Ltd. Warrants as of Q4 2020.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.